WASHINGTON – CMS’s recent decision to classify certain continuous glucose monitoring systems as DME is a positive step, but there are a few dominoes that need to fall before they are paid for, say stakeholders.
LOUISVILLE, Ky. – Amerita, the Specialty Infusion Division of PharMerica, has acquired Fairlawn, N.J.-based Nextron, a provider of certain specialty medications in the home. The move allows Amerita to further its expansion in the eastern United States.
CHICAGO – Ensuring compliance with sleep therapy can be time consuming and expensive for HME providers and patients alike. A new telemedicine platform from the American Academy of Sleep Medicine aims to make things easier.
WASHINGTON – The National Home Infusion Association seeks signatures for a letter that urges Congress to align the effective dates of switching to an average sales price reimbursement model for Part B infusion drugs and initiating payments for infusion services.
WASHINGTON – CMS published a sweeping proposed rule in the Federal Register on Jan. 12 outlining the qualifications needed for practitioners and suppliers to furnish and fabricate prosthetics and custom-fabricated orthotics, and the accreditation requirements needed to bill for them.